GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.2578
+0.0165 (6.84%)
At close: Oct 15, 2026, 4:00 PM EDT
0.2303
-0.0275 (-10.67%)
After-hours: Oct 15, 2026, 6:39 PM EDT

GeoVax Labs Revenue

In the year 2025, GeoVax Labs had annual revenue of $2.49M, down -37.06%. That makes GeoVax Labs the 43,813th largest company in the world by revenue and 6,155th in the United States.

Revenue (ttm)
$2.49M
Revenue Growth
-37.06%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
19
Market Cap
2.34M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.49M-1.47M-37.06%
Dec 31, 20243.95M--
Dec 31, 2023---
Dec 31, 202281.53K-303.98K-78.85%
Dec 31, 2021385.50K-1.44M-78.86%
Dec 31, 20201.82M647.76K55.09%
Dec 31, 20191.18M212.69K22.08%
Dec 31, 2018963.20K-112.07K-10.42%
Dec 31, 20171.08M246.35K29.72%
Dec 31, 2016828.92K400.84K93.64%
Dec 31, 2015428.08K-454.88K-51.52%
Dec 31, 2014882.96K-1.53M-63.48%
Dec 31, 20132.42M-239.78K-9.02%
Dec 31, 20122.66M-2.24M-45.77%
Dec 31, 20114.90M-285.37K-5.50%
Dec 31, 20105.19M1.52M41.36%
Dec 31, 20093.67M758.03K26.05%
Dec 31, 20082.91M2.67M1,127.90%
Dec 31, 2007237.00K-615.90K-72.21%
Dec 31, 2006852.91K182.44K27.21%
Dec 31, 2005670.47K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Jaguar Health27.82M
PMGC Holdings2.58M
SciSparc679.00K
Onconetix645.82K
BioRestorative Therapies357.87K
Silo Pharma54.08K
Revenue Rankings